GreenLight Clinical, a physician-led Clinical Research Organisation and laboratory, has announced that Dr Robert Lin has been appointed its chief executive officer.
Outgoing CEO Dr Grace Pei said, “We are very pleased to announce that Dr Robert Lin is taking over as our new CEO. I am confident that his extensive experience in the healthcare industry will help take GreenLight Clinical to the next level and beyond.”
Dr Lin has over 20 years of clinical and managerial experience. Dr Lin has extensive experience in managing private, public, and international hospitals and other facilities. His expertise spans strategic planning, improving operational efficiency, team building, and project management.
As CEO, Dr Lin will lead the organisation’s strategic direction while focusing on operational excellence, customer service, and innovation across its full suite of services, including both clinical research solutions and central laboratory services for biotech companies worldwide.
“I am excited to join GreenLight Clinical at this pivotal time,” said Dr Lin. “I look forward to working closely with our team to further strengthen our capabilities and deliver value-added services that meet our customers’ needs.”
GreenLight Clinical’s chairman Dr Andrew Chang added, “We are thrilled to welcome Robert as our new CEO; his deep expertise in managing global teams will be invaluable as we continue our mission to make clinical research processes more efficient through innovative solutions.”
